The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II study of preoperative chemotherapy plus bevacizumab with early salvage therapy based on FDG-PET response in patients with locally advanced gastric and GEJ adenocarcinoma.
Elizabeth Won
No relevant relationships to disclose
David Ilson
Research Funding - Bayer
David Paul Kelsen
No relevant relationships to disclose
Vivian E. Strong
No relevant relationships to disclose
Heiko Schöder
No relevant relationships to disclose
Yelena Yuriy Janjigian
No relevant relationships to disclose
Manish A. Shah
No relevant relationships to disclose
Daniel G. Coit
No relevant relationships to disclose
Murray F. Brennan
No relevant relationships to disclose
Marinela Capanu
No relevant relationships to disclose